Article and Video CATEGORIES
There's a single lung cancer trial being presented 6/1/08 at ASCO's Plenary Session, at which the most important cancer studies of the year are presented. This is on the FLEX trial that I described in a prior post, and which was already reported to be positive, at a press release all the way back in September of last year. We'll actually see the full data at the presentation, but the abstract just became publically available (here) and provides some additional information.
Some financial analysts have already described the findings and potential financial implications (here), but I'll give you an oncologist's perspective, and a sense of what my colleagues feel about the strength or weakness of the results and what they'll mean to the changing standards for lung cancer treatment, after the session Sunday.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi amitchouhan,
Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...
I was searching for this, Thank you so much for the info.
Glad to help. FYI, I just edited the link, which has the agenda and links to oncologists' bios. Plus, the link is also on our home page, https://cancergrace.org/
Hope to see...